Endocrine sensitivity of estrogen receptor‐positive breast cancer is negatively correlated with aspartate‐β‐hydroxylase expression

Although prognostic markers for early estrogen receptor (ER)‐positive breast cancer have been extensively developed, predictive markers for adjuvant endocrine therapy are still lacking. Focusing on the mechanisms underlying endocrine resistance, we investigated whether the endocrine sensitivity of E...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimoda, Masafumi, Hori, Ami, Wands, Jack R., Tsunashima, Ryo, Naoi, Yasuto, Miyake, Tomohiro, Tanei, Tomonori, Kagara, Naofumi, Shimazu, Kenzo, Kim, Seung Jin, Noguchi, Shinzaburo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715250/
https://www.ncbi.nlm.nih.gov/pubmed/28985022
http://dx.doi.org/10.1111/cas.13416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715250/
https://www.ncbi.nlm.nih.gov/pubmed/28985022
http://dx.doi.org/10.1111/cas.13416

Ejemplares similares